The efficacy of antiviral drug, HIV viral load and the immune response
Stephanie Yunfei Zhang, Mesfin Asfaw Taye

TL;DR
This paper extends a viral dynamics model to analyze how time-varying antiviral drug efficacy influences HIV viral load and immune response, revealing conditions for short-lived or sustained drug effects and their interaction with immune responses.
Contribution
It introduces a modified model incorporating time-dependent drug efficacy and analyzes the impact on viral load and immune response, including a simple solvable mathematical model.
Findings
Low drug efficacy leads to temporary viral load reduction.
High drug efficacy causes a sustained decrease in viral load.
CTL response increases the critical drug efficacy over time.
Abstract
Developing antiviral drugs is an exigent task since viruses mutate to overcome the effect of antiviral drugs. As a result, the efficacy of most antiviral drugs is short-lived. To include this effect, we modify the Neumann and Dahari model. Considering the fact that the efficacy of the antiviral drug varies in time, the differential equations introduced in the previous model systems are rewritten to study the correlation between the viral load and antiviral drug. The effect of antiviral drug that either prevents infection or stops the production of a virus is explored. First, the efficacy of the drug is considered to decreases monotonously as time progresses. In this case, our result depicts that when the efficacy of the drug is low, the viral load decreases and increases back in time revealing the effect of the antiviral drugs is short-lived. On the other hand, for the antiviral drug…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMathematical and Theoretical Epidemiology and Ecology Models · Evolution and Genetic Dynamics · COVID-19 epidemiological studies
